DYRK1A and neuroblastoma: In search of potential druggable targets in NB pathogenesis, we performed a systematic analysis of the correlation between expression of the Dual-specificity tYrosine phosphorylation-Regulated Kinase (DYRK) family members and neuroblastoma (NB) patient survival probability.